Targeting adenosine-2 B receptor : a potential metabolic immune checkpoint
Adenosine is an anti-inflammatory and immunosuppressive metabolite that binds to the adenosine receptors (AR) - A1R, A2AR, A2BR and A3R. Adenosine immunosuppression is mediated via A2Rs, with A2BR only activated by high adenosine concentration such as within solid tumor microenvironments (TME). A...
Saved in:
Main Author: | Tay, Hui Min |
---|---|
Other Authors: | Andreas Lundqvist |
Format: | Final Year Project |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/77108 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
by: Tay, Apple Hui Min, et al.
Published: (2023) -
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
by: Xiong, Zhewen, et al.
Published: (2023) -
IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION
by: TAY CHIN KANG JOHAN
Published: (2019) -
Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer
by: Mishra, Alok K., et al.
Published: (2024) -
Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
by: Huang, Yiqing, et al.
Published: (2022)